Patents by Inventor Jean-Stephane Gatot

Jean-Stephane Gatot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reactivation of HIV-1 gene expression to treat persistent HIV infection
    Patent number: 9943536
    Abstract: The present invention provides new methods of treatment of lentiviral infections, more particularly to treat latent retroviral HIV infections, present in cells of the infected subject, based on the re-activation of said viruses. The invention uses a combination therapy using several agents that result in strong re-activation of the latent HIV-virus that could destroy the infected cells and elicite an immune response in the subject. This could present further spread of the infection, with the ultimate aim to eradicate the virus completely in said subject.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: April 17, 2018
    Assignee: UNIVERSITE LIBRE DE BRUXELLES
    Inventors: Carine Van Lint, Olivier Rohr, Sophie Bouchat, Jean-Stephane Gatot
  • REACTIVATION OF HIV-1 GENE EXPRESSION TO TREAT PERSISTENT HIV INFECTION
    Publication number: 20150023907
    Abstract: The present invention provides new methods of treatment of lentiviral infections, more particularly to treat latent retroviral HIV infections, present in cells of the infected subject, based on the re-activation of said viruses. The invention uses a combination therapy using several agents that result in strong re-activation of the latent HIV-virus that could destroy the infected cells and elicite an immune response in the subject. This could present further spread of the infection, with the ultimate aim to eradicate the virus completely in said subject.
    Type: Application
    Filed: October 3, 2012
    Publication date: January 22, 2015
    Inventors: Carine Van Lint, Olivier Rohr, Sophie Bouchat, Jean-Stephane Gatot